authors request that the following clarification be noted. The Methods and Materials on p. 6987, line 28, indicated that mycobacterial cultures were grown in Middlebrook 7H9 broth (Difco) supplemented with ADC (albumin-dextrose complex) and 0.05% Tween 80. Middlebrook broth as originally formulated (23) and subsequently used for mycobacteria (24) contains glycerol. It has been brought to the authors' attention that the label on the Middlebrook-Dubos medium currently supplied by Difco states "if desired [each liter may contain] 2 ml glycerol or 0.05% Tween" (italics added). For the purposes of genetic transformation of BCG, the authors find that inclusion of 0.2% glycerol, as in the standard formulation, is required.
phasmids replicating as plasmids in E. coli and phage capable of lysogenizing the mycobacterial host. These temperate shuttle phasmids form turbid plaques on Mycobacterium smegmatis and, upon lysogenization, confer resistance to superinfection and integrate within the mycobacterial chromosome. When an Li shuttle phasmid containing a cloned gene conferring kanamycin resistance in E. coli was introduced into M. smegmatis, stable kanamycin-resistant colonies-i.e., lysogens-were obtained. Second, to develop a plasmid transformation system in mycobacteria, M. fortuitumlE. coli hybrid plasmids containing mycobacterial and E. coli replicons and a kanamycinresistance gene were constructed. When introduced into M. smegmatis or BCG (Mycobacterium tuberculosis typus bovinus var. Bacille-Calmette-Guerin) by electroporation, these shuttle plasmids conferred stable kanamycin resistance upon transformants. These systems should facilitate genetic analyses of mycobacterial pathogenesis and the development of recombinant mycobacterial vaccines.
Tuberculosis remains a devastating disease resulting in 3 million deaths per year, with greater than 10 million new cases annually predominantly found in the Third World (1). The incidence of tuberculosis in the United States is now increasing after a decline for the past 32 years (2) , largely due to the increase in acquired immunodeficiency syndrome (AIDS). Mycobacterium avium infection is responsible for a significant proportion of fatalities in AIDS patients, because it is refractory to all standard antibiotics (3) . Leprosy afflicts 10.5 million people, causing deformity in a third of its sufferers (4) . On the other hand, BCG (Mycobacterium tuberculosis typus bovinus var. Bacille-Calmette-Gudrin) is one of the most widely used vaccines in the world but has had variable effectiveness against tuberculosis and leprosy in different parts of the world (5, 6) . Clearly, greater understanding of the mechanisms of pathogenesis of tuberculosis and leprosy and strategies to develop improved vaccines and drugs effective against mycobacterial diseases are urgently needed.
Mycobacteria remain virtually uncharacterized genetically, and our goal was to develop a system in which genes could be transferred between Escherichia coli, an organism that is easy to manipulate genetically, and cultivable mycobacteria. Because of the paucity of mycobacterial plasmids and absence of selectable markers for mycobacteria, we initially developed a phage-based strategy by creating a shuttle phasmid vector. An E. coli cosmid, pHC79, was inserted (7) into a nonessential region of the mycobacteriophage TM4 genome, generating a phasmid that allows one to shuttle replicons among E. coli, Mycobacterium smegmatis, and BCG substrains. The problem of pseudolysogeny has confounded much work with mycobacteriophages (8) . Although TM4 was reported to lysogenize M. avium (9), we were unable to obtain a stable lysogenic state with this phage in M. smegmatis or BCG. Consequently, we have developed a methodology for expression of selectable markers by lysogeny and plasmid transformation in Mycobacterium, including BCG substrains.
METHODS AND MATERIALS
Bacterial Strains, Phages, and Cultures. The mycobacterial strains used were the M. smegmatis strain mc26 (7), a single-cell isolate of American Type Culture Collection (ATCC) 607; the unspeciated Mycobacterium ATCC 27199, lysogenized with mycobacteriophage LI (10); and the BCGPasteur substrain, seed lot 1173P2, obtained from the BCG Laboratory of the Institut Pasteur (Paris). The E. coli strains used were x2338 (11) and W5445 (12) and transformation protocols for these strains have been described. Mycobacterial cultures were grown in Middlebrook 7H9 broth (Difco) supplemented with ADC (albumin-dextrose complex) (Difco) and 0.05% Tween 80 (M-ADC-TW broth) with shaking at 37°C. Phage Li was obtained by plating the culture supernatant fluid from the Mycobacterium ATCC 27199 on mc26 cells with Dubos agar medium without Tween (GIBCO) containing 2 mM CaCl2. After plaque purification, hightitered plate lysates of Li, Li shuttle phasmids, and the virulent mycobacteriophage D29 (13) were prepared, and the phage particles were purified by CsCl equilibrium density centrifugation as described (7) .
Preparation of DNA and Hybridization Analyses. Chromosomal DNA was isolated by using a Braun homogenizer (packed cells were mixed with an equal volume of acidwashed 0.45-mm glass beads and homogenized for 2-6 min) and then phenol/chloroform extractions (C. Grosskinsky, J. E. Clark-Curtiss, W.R.J., and B.R.B., unpublished results). Phage and shuttle phasmid DNAs were isolated from phage particles after proteinase K digestion, phenol/chloroform extraction and extensive dialysis. Southern analyses Abbreviations: aph, aminoglycoside phosphotransferase; BCG, Mycobacterium tuberculosis typus bovinus var. Bacille-CalmetteGuerin; ADC, albumin-dextrose complex.
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were performed by using Biotrans (ICN) nylon membranes as described by the manufacturer. Li DNA was radiolabeled by using a nick-translation kit (Bethesda Research Laboratories) and [a-32P]dCTP (Amersham).
Construction of Li Shuttle Phasmids. Li shuttle phasmids were constructed in a manner similar to those constructed for the TM4 shuttle phasmids (7) . Briefly, the 50-kilobase (kb) mycobacteriophage Li DNA was ligated to form concatemers and partially digested with Sau3A to generate fragments 30-50 kb long. These fragments were ligated to the cosmid pHC79 (14) that had been cleaved with BamHI. This DNA was packaged into bacteriophage A heads by using Gigapack packaging extract (Stratagene, San Diego, CA), and the resulting packaged cosmid molecules were transduced into X2338 cells that were then plated on L agar (GIBCO) containing ampicillin (30 jug/ml). Each resulting ampicillinresistant clone contained a large piece of the Li phage genome with pHC79 inserted within it. Closed circular plasmid DNA extracted from a pool of 40,000 ampicillinresistant colonies therefore represented a library of pHC79 insertions in the Li genome. Phasmid DNA from this library was transfected into M. smegmatis protoplasts as described (7) . Five independent shuttle phasmids were obtained. All five formed turbid plaques on M. smegmatis and DNA isolated from these recombinant phage replicated as plasmids conferring ampicillin resistance in E. coli, thus confirming that these recombinant molecules were shuttle phasmids. Restriction analyses of these five Li shuttle phasmids showed differences (S.B.S., B.R.B., and W.R.J., unpublished results). For this work, we used the Li shuttle phasmid designated phAE15.
Cloning and Expression of the aph (Aminoglycoside Phosphotransferase) Gene into phAE15. The aph gene from Tn9O3 (15) was inserted into the Li shuttle phasmid, phAE15, by ligating phAE15 DNA concatemers cleaved at the unique EcoRI site to the TN903 EcoRI aph cassette (Pharmacia). The bacteriophage A cohesive end (cos) sequence present within the shuttle phasmid DNA permitted in vitro packaging of this ligated DNA into A phage heads. After in vitro packaging, the resulting A-packaged shuttle phasmids were transduced into the E. coli strain X2338 and cells were selected for both ampicillin and kanamycin resistance. Plasmid DNA was isolated from an E. coli transductant and transfected into mc26 protoplasts, and the resulting mycobacteriophage was designated phAE19. Lysogens were purified from turbid plaques arising after spotting phAE19 on agar containing mc26 cells. Putative lysogens were tested for release of phages and resistance to superinfection by Li.
Expression of the aph gene in mycobacteria was demonstrated by the growth ofM. smegmatis cells lysogenized with phAE19 on medium containing kanamycin. Dubos top agar was mixed with 5 x 107 cells and poured onto a Dubos agar plate containing kanamycin (15 ,ug/ml). Lysates of the Li shuttle phasmids phAE15 and phAE19 were passed through a 0.45-gm filter and diluted to 5 x 106 plaque-forming units/ml with MP buffer (7). Serial 1:10 dilutions (10 ,ul) were spotted in designated areas and the plates were incubated for 5 days at 37°C and then photographed.
Construction of E. coli-Mycobacterium Shuttle Plasmids. Plasmid pAL5000 DNA, isolated from Mycobacterium fortuitum as described (16) , was partially digested with Mbo I and linear fragments of 5 kb were isolated from an agarose gel after electrophoresis. These fragments were ligated to the positive selection vector pIJ666 (17) that had been cleaved with BamHI and EcoRV. This ligated DNA was transformed into E. coli W5445 and plated on L agar containing chloramphenicol (25 ,ug/ml). pIJ666 contains the neo (neomycin/ kanamycin phosphotransferase II) gene originating from TnS (18) , the P1SA origin of replication, and the chloramphenicol acetyltransferase gene from pACYC184 (19) . This plasmid has been described as a positive selection vector because the inverted terminator sequences present within pIJ666 must be separated by spacer DNA to allow for replication (17) . Thus, chloramphenicol-resistant transformants were expected to contain pAL5000 DNA. Approximately 200 chloramphenicol-resistant transformants were pooled and grown in mixed culture, from which plasmids were isolated and purified as described (20) .
Electroporation of Mycobacteria. Electroporation of mycobacterial cells was performed by using the Gene Pulser electroporator (Bio-Rad) and a modification of the protocol of Chassy and Flickinger (21) . Cultures of mc26 or BCG-Pasteur were grown in M-ADC-TW broth with shaking at 37TC. The mc26 cultures were harvested when they reached an A600 of 1.7 and BCG cultures were harvested when they reached 4.5
x 107 colony-forming units/ml. After centrifugation, the cells were washed in electroporation buffer (7 mM sodium phosphate/272 mM sucrose, pH 7.2) and resuspended in 10% of the original volume. D29 phage DNA or plasmid DNA (1 jig) was added to an electroporation cuvette containing 0.8 ml of mycobacterial cells. After a 10-min incubation on ice, the cells were subjected to a single pulse of electroporation (25 AF at 6250 V/cm). Phage transfections were assayed after an additional 10-min incubation on ice, by mixing the electroporated cells with sensitive cells and plating for plaqueforming units. Cells electroporated with plasmid DNA were also incubated on ice for 10 min and then mixed with an equal volume of M-ADC-TW broth. After a 2-hr incubation at 37°C, these cells were spread on 7H10 agar (Difco) plates supplemented with ADC containing kanamycin (10 ,ug/ml). Plates used for BCG experiments also contained cycloheximide (100 ,g/ml) to prevent mold contamination. Plates with M. smegmatis cells or BCG cells were incubated at 37°C for 7 days and 20-30 days, respectively. The kanamycin-resistant transformants were subcultured in M-ADC-TW broth con- Proc. Natl. Acad. Sci. USA 85 (1988) 6989 taining kanamycin (10 pug/ml). The M. smegmatis transformants (in agar) were also found to be resistant to chloramphenicol at >100 pgg/ml.
Isolation and Characterization of Plasmid DNA from Mycobacteria. Plasmid DNA was isolated from 1-ml samples of cells harvested at early stationary phase by a modification of the procedure of Birnboim and Doly (20) . Sequential incubations in lysozyme, alkaline/NaDodSO4, and high salt were each extended for 16 hr, and then the remainder of the protocol was followed. PL'smid DNA isolated from both M. smegmatis and BCG transformants would transform X2338 cells and confer both kanamycin and chloramphenicol resistance.
RESULTS AND DISCUSSION
Development of Shuttle Phasmids Capable of Lysogenizing Mycobacteria. The introduction of foreign DNA into mycobacteria by means of phages initially prompted us to screen a group of mycobacteriophages to identify those that might be temperate and stably lysogenize the rapidly growing M. smegmatis. One such phage, L1, had been reported (10, 22) A to produce turbid plaques on M. smegmatis; putative lysogens were resistant to superinfection and could be induced to produce phage. We confirmed these observations and have been able to demonstrate by Southern analysis that a prophage is integrated in the M. smegmatis chromosome (Fig.  1B, lanes 2 and 3) . Analysis ofmultiple, independent lysogens revealed identical patterns ofunique bands resulting from the phage integration, suggesting that Li phage integration is site specific (Fig. 1) .
Having established that Li stably lysogenizes M. smegmatis, we proceeded to construct Li shuttle phasmids by inserting the E. coli cosmid, pHC79, containing a ColEl origin of replication and an ampicillin-resistance gene for selection in E. coli into a nonessential region of the Li genome. The Li shuttle phasmid phAE15 that was constructed replicates in E. coli as a plasmid and in Mycobacterium as a phage and, like the parent phage, integrates into the M. smegmatis chromosome (Fig. 1, lanes 4 and 5) (Fig.  2A) . A 1.6-kb DNA fragment containing the aph gene from Tn9O3, which confers kanamycin resistance in E. coli, was inserted into phAE15 by a cosmid cloning strategy. The aph gene with EcoRI ends was ligated to linear phAE15 DNA and packaged in vitro into bacteriophage A heads, and the resulting recombinant molecules were transduced into E. coli. Closed circular phasmid DNA was isolated from an E. coli clone that was resistant to both ampicillin and kanamycin and was transfected into M. smegmatis protoplasts, yielding mycobacterial phage particles that had packaged phasmid DNA. This phasmid, designated phAE19, had the ability to lysogenize M. smegmatis cells and generate kanamycinresistant colonies (Fig. 2B) . In repeated experiments, kanamycin-resistant colonies did not arise from either spontaneous mutations of mc26 cells or mc26 cells lysogenized with phAE15. Mycobacteriophages spontaneously released from mc26 (phAE19) lysogens simultaneously cotransduced resistance to Li superinfection and kanamycin to recipient M. smegmatis cells. This demonstrates that the resistance to kanamycin results from expression of the cloned aph gene. The shuttle phasmid phAE19 also integrates into the M. smegmatis chromosome upon lysogenization (Fig. 1, lanes 6  and 7) . Preliminary data indicate that phAE19 can also lysogenize and confer kanamycin resistance upon BCG (data not shown). Kanamycin resistance thus represents a useful selectable marker for the mycobacteria. Overall, these results establish lysogeny as one means to introduce and express foreign genes in mycobacteria.
Plasmid Transformation of Mycobacteria. Plasmid-based genetic systems extend the capabilities of phages by offering increased cloning capacity, ease of DNA manipulation, and increased copy number. Because plasmids from M. smegmatis had not been described and genetic manipulation in mycobacteria is difficult, we sought to construct a shuttle plasmid vector that expressed kanamycin resistance and was capable of replication and of expressing genes in E. coli and Mycobacterium. To ensure a functional replicon for mycobacteria, we randomly inserted an E. coli plasmid, pIJ666 (17) , containing the neo gene from TnS (17, 18) , the P15A origin of replication, and chloramphenicol acetyltransferase gene from pACYC184 (19) , into a plasmid, pAL5000 (16) , that replicates in M. fortuitum. Fig. 3A outlines the construction of the pIJ666::pAL5000 library. Successful transformation of this library into M. smegmatis spheroplasts by standard techniques has been problematic, possibly due to the difficulty in regenerating viable cells from spheroplasts. DNA was therefore introduced directly into intact M. smegmatis cells by electroporation. Initially conditions were developed for electroporation with lytic D29 phage DNA to monitor uptake; it yielded >5 x 103 plaque-forming units/,g. By using optimal conditions, electroporation of the pIJ666:: pAL5000 DNA library into M. smegmatis yielded 1-10 kanamycin-resistant transformants per ,g of library DNA in six independent experiments. These transformants were also found to be resistant to chloramphenicol, thus demonstrating the expression of the chloramphenicol acetyltransferase gene in M. smegmatis. Plasmid DNA isolated from pools of M. smegmatis transformants from three experiments yielded kanamycin-resistant E. coli and M. smegmatis cells when retransformed. Although pIJ666 was inserted at different sites within pAL5000 in many of the isolated E. coli transformants (data not shown), at least three shuttle plasmids were stable in both bacterial genera (Fig. 3B) . Finally, these methods have made it possible to transform BCG substrains with the pIJ666::pAL5000 recombinant library, with stable expression of kanamycin resistance (Fig. 4) possible to insertionally inactivate and mark specific genes of pathogenic M. tuberculosis, either by homologous recombination or by transposon-mediated insertion, with the aim of identifying specific genetic determinants required for virulence and pathogenesis. By specifically deleting or replacing those genes, it may be possible to develop a more specific and effective attenuated vaccine against tuberculosis than the BCG vaccine. Alternatively, as specific protective antigens for tuberculosis and leprosy are identified by studying antigens recognized by T cells from resistant individuals, it will now be possible to incorporate and express them in existing BCG vaccines. With the genetic approaches described here, we have established that the neo gene encoding kanamycin resistance can be stably expressed in certain BCG substrains. Since BCG is currently one of the most widely used vaccines in the world-and one of the safest-it is our hope that the genetic systems described here will permit the development of BCG into a multivaccine vehicle, capable of simultaneously expressing genes encoding protective antigens of a variety of bacterial, viral, and parasitic pathogens.
